0001104659-20-010828.txt : 20200204 0001104659-20-010828.hdr.sgml : 20200204 20200204184115 ACCESSION NUMBER: 0001104659-20-010828 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200131 FILED AS OF DATE: 20200204 DATE AS OF CHANGE: 20200204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dexcel Pharma Technologies Ltd. CENTRAL INDEX KEY: 0001720007 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37521 FILM NUMBER: 20575559 BUSINESS ADDRESS: STREET 1: 1 DEXCEL STREET CITY: OR AKIVA STATE: L3 ZIP: 3060000 BUSINESS PHONE: 97246364040 MAIL ADDRESS: STREET 1: 1 DEXCEL STREET CITY: OR AKIVA STATE: L3 ZIP: 3060000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oren Dan CENTRAL INDEX KEY: 0001636701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37521 FILM NUMBER: 20575560 MAIL ADDRESS: STREET 1: 1 DEXCEL STREET CITY: OR AKIVA STATE: L3 ZIP: 30600000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intec Pharma Ltd. CENTRAL INDEX KEY: 0001638381 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 BUSINESS PHONE: 97225864657 MAIL ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 4 1 tv537617_4.xml OWNERSHIP DOCUMENT X0306 4 2020-01-31 1 0001638381 Intec Pharma Ltd. NTEC 0001720007 Dexcel Pharma Technologies Ltd. 1 DEXCEL STREET OR AKIVA L3 3060000 ISRAEL 0 0 1 0 0001636701 Oren Dan 1 DEXCEL STREET OR AKIVA L3 3060000 ISRAEL 0 0 1 0 Ordinary Shares 2020-01-31 4 S 0 725951 0.309 D 4424897 D Ordinary Shares 2020-02-03 4 S 0 80000 0.318 D 4344897 D Ordinary Shares 2020-02-04 4 S 0 110000 0.290 D 4234897 D Dexcel Pharma Technologies Ltd ("DPT") and Dan Oren, DPT's Executive Chairman, are filing this Form 4 because they have beneficial ownership over ordinary shares of Intec Pharma Ltd. The Ordinary Shares are directly owned by DPT. Mr. Oren is ultimately the sole shareholder of DPT. The price reported in Column 4 is the weighted average price. The Ordinary Shares were sold in multiple transactions at prices ranging from $0.300 to $0.325, inclusive. The price reported in Column 4 is the weighted average price. The Ordinary Shares were sold in multiple transactions at prices ranging from $0.300 to $0.324, inclusive. The price reported in Column 4 is the weighted average price. The Ordinary Shares were sold in multiple transactions at prices ranging from $0.290 to $0.294, inclusive. The Reporting Persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. /s/ Dexcel Pharma Technologies Ltd. by Dan Oren, Executive Chairman 2020-02-04 /s/ Dan Oren 2020-02-04